premature ovarian failure DHEA dehydroepiandrosterone treatment, DHEA supplementation premature ovarian insufficiency, dehydroepiandrosterone ovarian reserve diminished fertility, premature ovarian failure hormonal therapy options, DHEA premature menopause reproductive outcomes, adrenal androgen supplementation ovarian failure, dehydroepiandrosterone fertility treatment poor ovarian response, premature ovarian insufficiency androgen supplementation, DHEA ovarian function restoration premenopause, Mamas DHEA premature ovarian failure fertility sterility
PMID 18321501 18321501 DOI 10.1016/j.fertnstert.2007.11.055 10.1016/j.fertnstert.2007.11.055
Keywords
Adult, Dehydroepiandrosterone/therapeutic Use, Estradiol/blood, Female, Fertility Agents, Female/therapeutic Use, Follicle Stimulating Hormone, Human/blood, Humans, Infertility, Female/blood/drug Therapy/etiology, Luteinizing Hormone/blood, Pilot Projects, Pregnancy, Pregnancy Rate, Primary Ovarian Insufficiency/blood/complications/drug Therapy, Treatment Outcome, Fertility Agents, Female, Follicle Stimulating Hormone, Human, Dehydroepiandrosterone, Estradiol, Luteinizing Hormone